Bayer Total Non-Operating Income/Expense 2012-2025 | BAYRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Bayer annual total non-operating income/expense for 2025 was $-2.322B, a 5.19% decline from 2024.
Bayer annual total non-operating income/expense for 2024 was $-2.449B, a 1.32% increase from 2023.
Bayer annual total non-operating income/expense for 2023 was $-2.417B, a 2.06% decline from 2022.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Bayer annual total non-operating income/expense for 2025 was $-2.322B, a 5.19% decline from 2024.
Bayer annual total non-operating income/expense for 2024 was $-2.449B, a 1.32% increase from 2023.
Bayer annual total non-operating income/expense for 2023 was $-2.417B, a 2.06% decline from 2022.